Big Gain For Clarus Therapeutics Holdings Inc.

Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ) soared at $1.22, representing a gain of 58.4%. On Fri, Mar 18, 2022, CRXT:NASDAQ hit a New 2-Week High of $0.77. The stock appeared on our News Catalysts scanner on Wed, Mar 16, 2022 at 10:01 AM in the 'BIOTECH' category. From Mon, Mar 07, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days

About Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ)

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.